NCT05753761

Brief Summary

Goal of research program: To understand person-specific factors, such as imaging markers and activity patterns early after stroke, that may guide precision rehabilitation to optimize function and improve recovery. Objectives:

  1. 1.Test the effect of reducing sedentary behaviour early after stroke on functional mobility and global disability outcomes.
  2. 2.Determine the impact of neuroimaging biomarkers (e.g. leukoaraiosis) on response to rehabilitation.
  3. 3.Explore the predictive value of accelerometry as an adjunct to the subjective modified Rankin Scale (mRS) to assess functional disability after stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Jul 2023

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 3, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

July 10, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 26, 2025

Completed
Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

2.4 years

First QC Date

February 10, 2023

Last Update Submit

April 7, 2026

Conditions

Keywords

StrokeMovement BehaviorsLeukoaraiosisWhole Day

Outcome Measures

Primary Outcomes (2)

  • Change from Baseline modified Rankin Scale (mRS) at 6 and 12 weeks

    Measure of global disability using the mRS score \[grade 0-2 vs ≥3\]

    6 and 12 weeks

  • Change from Baseline Timed-Up and Go (TUG) test at 6 and 12 weeks

    Functional mobility will be assessed using the TUG test

    6 and 12 weeks

Secondary Outcomes (7)

  • Change from Baseline ActivPAL-derived movement behaviors at 6 and 12 weeks

    6 and 12 weeks

  • Change from Baseline 10-meter walk test at 6 and 12 weeks

    6 and 12 weeks

  • Change from Baseline 6-minute walk test at 6 and 12 weeks

    6 and 12 weeks

  • Change from Baseline Montreal Cognitive Assessment (MoCA) at 6 and 12 weeks

    6 and 12 weeks

  • Change from Baseline EuroQol (EQ)-5D at 6 and 12 weeks

    6 and 12 weeks

  • +2 more secondary outcomes

Study Arms (2)

Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS)

EXPERIMENTAL

Additional to usual care, the experimental arm will undergo a theory-based behaviour change intervention to improve stepping time relative to reducing sedentary behaviour.

Behavioral: Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention

Usual care:

ACTIVE COMPARATOR

The control arm program will consist of usual inpatient care including therapeutic mobilization by the physical therapy team and general mobilization, as tolerated, by the nursing team.

Behavioral: Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS) intervention

Interventions

Using baseline accelerometry data, personalized goals of replacing sedentary time with stepping time will be developed.

Behaviour- & Imaging-Guided Stepping Training Early Post-Stroke (BIG STEPS)Usual care:

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Within 3 months of stroke onset
  • Aged ≥ 18 years
  • Medically stable as deemed by physicians
  • Able to walk at least 5 meters with/without gait aid
  • Ongoing walking goals (walk speed \<1.0 meter/sec)

You may not qualify if:

  • Have another condition such as multiple sclerosis or Parkinson's disease, or active cancer
  • Uncontrolled high blood pressure
  • Unstable cardiovascular condition
  • Unable to understand or follow instructions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospital

Edmonton, Alberta, T6G 2B7, Canada

Location

Related Publications (1)

  • Okusanya D, Ezeugwa JC, Khan A, Buck B, Jickling GC, Ezeugwu VE. The whole day matters after stroke: Study protocol for a randomized controlled trial investigating the effect of a 'sit less, move more, sleep better' program early after stroke. PLoS One. 2023 Dec 7;18(12):e0290515. doi: 10.1371/journal.pone.0290515. eCollection 2023.

MeSH Terms

Conditions

StrokeLeukoaraiosis

Interventions

Methods

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Victor Ezeugwu, PhD

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 10, 2023

First Posted

March 3, 2023

Study Start

July 10, 2023

Primary Completion

November 26, 2025

Study Completion

November 26, 2025

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Study team will have access to individual participant data.

Locations